Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-014624
Filing Date
2017-12-15
Accepted
2017-12-14 17:33:31
Documents
59
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1114463
2 ex31.htm EX-31 18535
3 ex32.htm EX-32 8714
4 image_001.jpg GRAPHIC 4487
5 image_002.jpg GRAPHIC 27645
6 image_003.jpg GRAPHIC 49611
7 image_004.jpg GRAPHIC 13542
  Complete submission text file 0001493152-17-014624.txt   3911908

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ptlf-20170831.xml EX-101.INS 454818
9 XBRL SCHEMA FILE ptlf-20170831.xsd EX-101.SCH 45083
10 XBRL CALCULATION FILE ptlf-20170831_cal.xml EX-101.CAL 45049
11 XBRL DEFINITION FILE ptlf-20170831_def.xml EX-101.DEF 148178
12 XBRL LABEL FILE ptlf-20170831_lab.xml EX-101.LAB 301056
13 XBRL PRESENTATION FILE ptlf-20170831_pre.xml EX-101.PRE 233297
Mailing Address 38 WEST MAIN STREET HANCOCK MD 21750
Business Address 38 WEST MAIN STREET HANCOCK MD 21750 844-473-8543
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

EIN.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52445 | Film No.: 171257062
SIC: 2860 Industrial Organic Chemicals